Vericel Corp. (VCEL)
58.39
+3.77
(+6.90%)
USD |
NASDAQ |
Nov 09, 16:00
58.60
+0.21
(+0.36%)
After-Hours: 18:05
Vericel Gross Profit (Annual) : 205.60M for Dec. 31, 2025
Gross Profit (Annual) Chart
Historical Gross Profit (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 205.60M |
| December 31, 2024 | 172.11M |
| December 31, 2023 | 135.58M |
| December 31, 2022 | 109.79M |
| December 31, 2021 | 106.02M |
| December 31, 2020 | 84.23M |
| December 31, 2019 | 80.28M |
| December 31, 2018 | 58.70M |
| December 31, 2017 | 33.57M |
| December 31, 2016 | 26.08M |
| December 31, 2015 | 24.70M |
| December 31, 2014 | 14.00M |
| December 31, 2013 | -0.474M |
| December 31, 2012 | -0.634M |
| December 31, 2011 | -0.633M |
| Date | Value |
|---|---|
| December 31, 2010 | -0.016M |
| June 30, 2009 | -0.634M |
| June 30, 2008 | -0.266M |
| June 30, 2007 | 0.156M |
| June 30, 2006 | 0.526M |
| June 30, 2005 | 0.594M |
| June 30, 2004 | 1.022M |
| June 30, 2003 | -5.696M |
| June 30, 2002 | -4.753M |
| June 30, 2001 | -4.097M |
| June 30, 2000 | -0.101M |
| June 30, 1999 | 0.579M |
| June 30, 1998 | 0.00 |
| June 30, 1997 | 0.00 |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (Annual) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 971.62M |
| Alnylam Pharmaceuticals, Inc. | 3.032B |
| Anika Therapeutics, Inc. | 63.81M |
| Savara, Inc. | -0.245M |
| Biogen, Inc. | 6.454B |